Iron in human atheroma and LDL oxidation by macrophages following erythrophagocytosis.
about
Natural-resistance-associated macrophage protein 1 is an H+/bivalent cation antiporterAtherogenesis and iron: from epidemiology to cellular level.The iron hypothesis:does iron play a role in atherosclerosis?Haptoglobin and CD163: captor and receptor gating hemoglobin to macrophage lysosomes.SLC11A1 (formerly NRAMP1) and disease resistance.Haptoglobin polymorphism and body iron stores.Dietary micronutrient intakes are associated with markers of inflammation but not with markers of subclinical atherosclerosis.Iron and peripheral arterial disease: revisiting the iron hypothesis in a different light.The Nature of Iron Deposits Differs between Symptomatic and Asymptomatic Carotid Atherosclerotic Plaques.Age-related accumulation of non-heme ferric and ferrous iron in mouse ovarian stroma visualized by sensitive non-heme iron histochemistryImproved in vivo human carotid artery wall T₂ estimationIn vivo atherosclerotic plaque characterization using magnetic susceptibility distinguishes symptom-producing plaques.Regulation and therapeutic strategies of 4-hydroxy-2-nonenal metabolism in heart disease.Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.On the cytoprotective role of ferritin in macrophages and its ability to enhance lysosomal stability.Fragmentation of extracellular matrix by hypochlorous acid.Association between hemoglobin levels and arterial stiffness for general Japanese population in relation to body mass index status: The Nagasaki Islands study.Secretion of ferritin by iron-laden macrophages and influence of lipoproteins.Overexpression of transferrin receptor and ferritin related to clinical symptoms and destabilization of human carotid plaques.Involvement of endotoxins or tumor necrosis factor-alpha in macrophage-mediated oxidation of low density lipoprotein.Prognostic evaluation of catalytic iron in patients with acute coronary syndromes.Hydrogen Sulfide Abrogates Hemoglobin-Lipid Interaction in Atherosclerotic Lesion.Antioxidants inhibit low density lipoprotein oxidation less at lysosomal pH: A possible explanation as to why the clinical trials of antioxidants might have failed.
P2860
Q28359596-71FA4999-8C9A-4758-8EC6-44D42AB4FEE2Q33595279-972413EF-6051-4B73-BD8E-65EEC11F8528Q34014713-69947199-0E24-47F8-AF2B-7931903AF350Q34115973-1C736215-0616-43BD-9AAC-BCFE2E01BE6BQ34459115-BA9A5BFB-3C98-4777-B480-D923A168946CQ34634285-0D0D4483-7635-481C-BF5E-F8FF2F4ABA5BQ35112090-833BFAB3-932B-4102-B3DD-FAAF67C8AD9DQ35677941-166F336E-23E3-4D86-8041-6B350A8F0F51Q35852399-9F544029-09C0-4B6E-9790-5FBD990FF045Q35955926-F2BE4C4E-8137-4353-A312-07AAE518012FQ36598449-66BE7930-C161-4653-BD82-E4010903F470Q37311902-27165DEC-9AFB-4C42-AF2E-42A8FD6F0329Q38163001-208D729F-D2C1-4875-9A76-3CA11CA62FA1Q38811310-BF7A13CA-36F3-4B4F-BB8C-3F1072630C80Q41056041-AA612946-3EB1-4822-AF0B-A1F65DBA7778Q41978147-76A83701-390C-4313-90E8-31B92BA9A1C6Q43715595-9AD548B9-21B0-402C-8F9A-B74BBC929340Q45129263-CA1AD9EF-2AB9-4CFE-8C5F-97953DF1B929Q46619854-E0D710D8-1885-482D-A9B9-BC9276B877F5Q47763936-0E71BB91-3FDD-47CA-A9F4-5551B15EFD99Q47918550-4CD15973-41AB-47B0-A17E-D870423A993EQ52645873-3A1D420F-DB41-4BEE-A58E-3CEB2877B9D4Q52666679-ACFB1E6A-CCBA-4EF5-9E97-9807D65D7EBF
P2860
Iron in human atheroma and LDL oxidation by macrophages following erythrophagocytosis.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Iron in human atheroma and LDL oxidation by macrophages following erythrophagocytosis.
@en
type
label
Iron in human atheroma and LDL oxidation by macrophages following erythrophagocytosis.
@en
prefLabel
Iron in human atheroma and LDL oxidation by macrophages following erythrophagocytosis.
@en
P2093
P1433
P1476
Iron in human atheroma and LDL oxidation by macrophages following erythrophagocytosis.
@en
P2093
P356
10.1016/0021-9150(96)05817-0
P577
1996-07-01T00:00:00Z